Florida Biologix - - BioPharm International


Florida Biologix

BioPharm International
Volume 19, Issue 12

Company Description

Florida Biologix is a nonprofit contract manufacturing and testing organization whose primary focus is cGMP compliant production of Phase 1 and 2 clinical trial material on time and at reasonable prices. Our senior cGMP manufacturing, Quality Control and Quality Assurance managers have over 90 years of combined biopharmaceutical manufacturing experience. Our operational model, location, and affiliations help to keep costs low.

Markets Served

We provide a wide range of services to the biopharmaceutical industry, biomedical research institutions, and academia.

Products and Services

Our services include: cell line engineering, cGMP cell banking, upstream and downstream process design, process and assay development, cGMP production of proteins expressed in mammalian cells (including monoclonal antibodies, recombinant proteins, enzymes, vaccines and other biomolecules), purification, aseptic vial filling (including small molecules, nucleic acids and proteins), product testing, and regulatory support. Process development and scale-up of non-GMP material is also available.


Our new, 16,000-sq. ft. validated, multiproduct facility has been designed and built with process and support equipment to provide timely, high-quality, cGMP compliant Phase 1 and Phase 2 contract manufacturing and testing services. The 5,000 sq. ft. process development laboratories, located in a separate building adjacent to the cGMP facility, are equipped with the same state-of-the-art equipment as the manufacturing site.

13702 Innovation Drive
Alachua, FL 32615




blog comments powered by Disqus



Lilly to Acquire Novartis Animal Health
April 22, 2014
Novartis and GSK Trade Assets
April 22, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here